List of Chapters/Sections(Table Of Content)
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent TB Infection Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mantoux Test / Tuberculin Skin Test (TST)
1.2.3 Interferon-Gamma Release Assay (IGRA)
1.3 Market by Application
1.3.1 Global Latent TB Infection Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Public and Student Health
1.3.4 Physician Offices and Clinics
1.3.5 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Latent TB Infection Testing Market Perspective (2017-2028)
2.2 Latent TB Infection Testing Growth Trends by Region
2.2.1 Latent TB Infection Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Latent TB Infection Testing Historic Market Size by Region (2017-2022)
2.2.3 Latent TB Infection Testing Forecasted Market Size by Region (2023-2028)
2.3 Latent TB Infection Testing Market Dynamics
2.3.1 Latent TB Infection Testing Industry Trends
2.3.2 Latent TB Infection Testing Market Drivers
2.3.3 Latent TB Infection Testing Market Challenges
2.3.4 Latent TB Infection Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent TB Infection Testing Players by Revenue
3.1.1 Global Top Latent TB Infection Testing Players by Revenue (2017-2022)
3.1.2 Global Latent TB Infection Testing Revenue Market Share by Players (2017-2022)
3.2 Global Latent TB Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Latent TB Infection Testing Revenue
3.4 Global Latent TB Infection Testing Market Concentration Ratio
3.4.1 Global Latent TB Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent TB Infection Testing Revenue in 2021
3.5 Latent TB Infection Testing Key Players Head office and Area Served
3.6 Key Players Latent TB Infection Testing Product Solution and Service
3.7 Date of Enter into Latent TB Infection Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent TB Infection Testing Breakdown Data by Type
4.1 Global Latent TB Infection Testing Historic Market Size by Type (2017-2022)
4.2 Global Latent TB Infection Testing Forecasted Market Size by Type (2023-2028)
5 Latent TB Infection Testing Breakdown Data by Application
5.1 Global Latent TB Infection Testing Historic Market Size by Application (2017-2022)
5.2 Global Latent TB Infection Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Latent TB Infection Testing Market Size (2017-2028)
6.2 North America Latent TB Infection Testing Market Size by Type
6.2.1 North America Latent TB Infection Testing Market Size by Type (2017-2022)
6.2.2 North America Latent TB Infection Testing Market Size by Type (2023-2028)
6.2.3 North America Latent TB Infection Testing Market Share by Type (2017-2028)
6.3 North America Latent TB Infection Testing Market Size by Application
6.3.1 North America Latent TB Infection Testing Market Size by Application (2017-2022)
6.3.2 North America Latent TB Infection Testing Market Size by Application (2023-2028)
6.3.3 North America Latent TB Infection Testing Market Share by Application (2017-2028)
6.4 North America Latent TB Infection Testing Market Size by Country
6.4.1 North America Latent TB Infection Testing Market Size by Country (2017-2022)
6.4.2 North America Latent TB Infection Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Latent TB Infection Testing Market Size (2017-2028)
7.2 Europe Latent TB Infection Testing Market Size by Type
7.2.1 Europe Latent TB Infection Testing Market Size by Type (2017-2022)
7.2.2 Europe Latent TB Infection Testing Market Size by Type (2023-2028)
7.2.3 Europe Latent TB Infection Testing Market Share by Type (2017-2028)
7.3 Europe Latent TB Infection Testing Market Size by Application
7.3.1 Europe Latent TB Infection Testing Market Size by Application (2017-2022)
7.3.2 Europe Latent TB Infection Testing Market Size by Application (2023-2028)
7.3.3 Europe Latent TB Infection Testing Market Share by Application (2017-2028)
7.4 Europe Latent TB Infection Testing Market Size by Country
7.4.1 Europe Latent TB Infection Testing Market Size by Country (2017-2022)
7.4.2 Europe Latent TB Infection Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent TB Infection Testing Market Size (2017-2028)
8.2 Asia-Pacific Latent TB Infection Testing Market Size by Type
8.2.1 Asia-Pacific Latent TB Infection Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Latent TB Infection Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Latent TB Infection Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Latent TB Infection Testing Market Size by Application
8.3.1 Asia-Pacific Latent TB Infection Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Latent TB Infection Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Latent TB Infection Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Latent TB Infection Testing Market Size by Region
8.4.1 Asia-Pacific Latent TB Infection Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Latent TB Infection Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Latent TB Infection Testing Market Size (2017-2028)
9.2 Latin America Latent TB Infection Testing Market Size by Type
9.2.1 Latin America Latent TB Infection Testing Market Size by Type (2017-2022)
9.2.2 Latin America Latent TB Infection Testing Market Size by Type (2023-2028)
9.2.3 Latin America Latent TB Infection Testing Market Share by Type (2017-2028)
9.3 Latin America Latent TB Infection Testing Market Size by Application
9.3.1 Latin America Latent TB Infection Testing Market Size by Application (2017-2022)
9.3.2 Latin America Latent TB Infection Testing Market Size by Application (2023-2028)
9.3.3 Latin America Latent TB Infection Testing Market Share by Application (2017-2028)
9.4 Latin America Latent TB Infection Testing Market Size by Country
9.4.1 Latin America Latent TB Infection Testing Market Size by Country (2017-2022)
9.4.2 Latin America Latent TB Infection Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent TB Infection Testing Market Size (2017-2028)
10.2 Middle East & Africa Latent TB Infection Testing Market Size by Type
10.2.1 Middle East & Africa Latent TB Infection Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Latent TB Infection Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Latent TB Infection Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Latent TB Infection Testing Market Size by Application
10.3.1 Middle East & Africa Latent TB Infection Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Latent TB Infection Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Latent TB Infection Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Latent TB Infection Testing Market Size by Country
10.4.1 Middle East & Africa Latent TB Infection Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Latent TB Infection Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
11.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Details
11.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
11.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Introduction
11.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2017-2022)
11.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Developments
11.2 Pharmstandard (Generium Pharmaceutical)
11.2.1 Pharmstandard (Generium Pharmaceutical) Company Details
11.2.2 Pharmstandard (Generium Pharmaceutical) Business Overview
11.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Introduction
11.2.4 Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2017-2022)
11.2.5 Pharmstandard (Generium Pharmaceutical) Recent Developments
11.3 Sanofi S.A./Sanofi Pasteur Ltd.
11.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Details
11.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
11.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Introduction
11.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2017-2022)
11.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Recent Developments
11.4 Statens Serum Institut (SSI)
11.4.1 Statens Serum Institut (SSI) Company Details
11.4.2 Statens Serum Institut (SSI) Business Overview
11.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Introduction
11.4.4 Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2017-2022)
11.4.5 Statens Serum Institut (SSI) Recent Developments
11.5 Autoimmun Diagnostika (AID) GmbH
11.5.1 Autoimmun Diagnostika (AID) GmbH Company Details
11.5.2 Autoimmun Diagnostika (AID) GmbH Business Overview
11.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Introduction
11.5.4 Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2017-2022)
11.5.5 Autoimmun Diagnostika (AID) GmbH Recent Developments
11.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
11.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Details
11.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
11.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Introduction
11.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2017-2022)
11.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Developments
11.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
11.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Details
11.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
11.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Introduction
11.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2017-2022)
11.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Developments
11.8 Immunoshop India Pvt. Ltd.
11.8.1 Immunoshop India Pvt. Ltd. Company Details
11.8.2 Immunoshop India Pvt. Ltd. Business Overview
11.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Introduction
11.8.4 Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2017-2022)
11.8.5 Immunoshop India Pvt. Ltd. Recent Developments
11.9 Qiagen N.V.
11.9.1 Qiagen N.V. Company Details
11.9.2 Qiagen N.V. Business Overview
11.9.3 Qiagen N.V. Latent TB Infection Testing Introduction
11.9.4 Qiagen N.V. Revenue in Latent TB Infection Testing Business (2017-2022)
11.9.5 Qiagen N.V. Recent Developments
11.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
11.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Details
11.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
11.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Introduction
11.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2017-2022)
11.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Developments
11.11 SD Biosensor, Inc.
11.11.1 SD Biosensor, Inc. Company Details
11.11.2 SD Biosensor, Inc. Business Overview
11.11.3 SD Biosensor, Inc. Latent TB Infection Testing Introduction
11.11.4 SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2017-2022)
11.11.5 SD Biosensor, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
